NADEJDA TIHOMIROVS: Open Payments
NPI 1578159968 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$508 in 17 payments from 9 companies in 2025. Trend: 2023 $623 · 2024 $863 · 2025 $508
Food & beverage: $508
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 1 | $125 |
| ABBVIE INC. | 4 | $121 |
| Kowa Pharmaceuticals America, Inc. | 2 | $48 |
| SCILEX PHARMACEUTICALS INC. | 2 | $45 |
| SHIELD THERAPEUTICS INC | 2 | $43 |
| Amgen Inc. | 2 | $40 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
| Ardelyx, Inc. | 1 | $29 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
Products named: RECORLEV, QULIPTA, ZORYVE, ZTLido, ACCRUFER, OTEZLA, XIFAXAN, UBRELVY.
Industry payments across NY — which companies pay providers there.
